重组组织型纤溶酶原激活剂与尿激酶治疗外周动脉闭塞的比较。 - Suppr | 超能文献

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.

作者信息

Dawson K J, Hamilton G

出版信息

Radiology. 1991 Jan;178(1):283-4. doi: 10.1148/radiology.178.1.1898537.

DOI:10.1148/radiology.178.1.1898537

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.重组组织型纤溶酶原激活剂与尿激酶治疗外周动脉闭塞的比较。

Radiology. 1991 Jan;178(1):283-4. doi: 10.1148/radiology.178.1.1898537.

2

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.重组组织型纤溶酶原激活剂与尿激酶治疗外周动脉和移植物闭塞的随机试验

Radiology. 1990 Apr;175(1):75-8. doi: 10.1148/radiology.175.1.2107563.

3

Changing trends in thrombolytic therapy for lower limb ischaemia.下肢缺血溶栓治疗的趋势变化

Int Angiol. 1994 Jun;13(2):93-5.

4

Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.阿替普酶作为尿激酶的替代药物。导管定向溶栓治疗咨询小组。

J Vasc Interv Radiol. 2000 Mar;11(3):279-87. doi: 10.1016/s1051-0443(07)61418-3.

5

Efficacy of tissue plasminogen activator and urokinase in a canine model of prosthetic graft thrombosis.组织型纤溶酶原激活剂和尿激酶在人工血管移植物血栓形成犬模型中的疗效

Arch Surg. 1986 Jul;121(7):782-8. doi: 10.1001/archsurg.1986.01400070048010.

6

[Thrombotic and thromboembolic occlusions of leg arteries and bypasses. Short-term versus long-term lysis].[腿部动脉及旁路的血栓形成与血栓栓塞性闭塞。短期与长期溶栓]

Rofo. 1993 Jun;158(6):536-41. doi: 10.1055/s-2008-1032697.

7

[Comparison of urokinase and tissue-type plasminogen activator in transcatheter arterial fibrinolysis].[尿激酶与组织型纤溶酶原激活剂在经导管动脉溶栓中的比较]

Radiol Med. 1994 Jul-Aug;88(1-2):93-9.

8

Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂-1抗性糖基化变体的溶栓特性比较

Thromb Haemost. 1994 Jul;72(1):98-104.

9

Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator.

Circulation. 1986 Sep;74(3 Pt 2):I21-4.

10

Urokinase infusion in total occlusion of peripheral vascular disease.尿激酶输注治疗周围血管疾病完全闭塞

Kans Med. 1991 Mar;92(3):73-5.

引用本文的文献

1

Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.阿替普酶。对其在急性心肌梗死以外血管疾病中的药理学及治疗应用的重新评估。

Drugs. 1995 Aug;50(2):289-316. doi: 10.2165/00003495-199550020-00007.